Eric Vasiliauskas
About
In The Last Decade
Eric Vasiliauskas
26 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Genetics 1.0k
- Epidemiology 823
- Immunology 350
- Surgery 332
- Rheumatology 146
Countries citing papers authored by Eric Vasiliauskas
This map shows the geographic impact of Eric Vasiliauskas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Vasiliauskas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Vasiliauskas more than expected).
Fields of papers citing papers by Eric Vasiliauskas
This network shows the impact of papers produced by Eric Vasiliauskas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Vasiliauskas. The network helps show where Eric Vasiliauskas may publish in the future.
Co-authorship network of co-authors of Eric Vasiliauskas
This figure shows the co-authorship network connecting the top 25 collaborators of Eric Vasiliauskas. A scholar is included among the top collaborators of Eric Vasiliauskas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Vasiliauskas. Eric Vasiliauskas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 19 | |
| 5 | 1 | |
| 6 | 8 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 1 | |
| 10 | 20 | |
| 11 | 6 | |
| 12 | 132 | |
| 13 | 16 | |
| 14 | 21 | |
| 15 | 32 | |
| 16 | 128 | |
| 17 | 1 | |
| 18 | 20 | |
| 19 | Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease breakdown → | 875 |
| 20 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.